Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762825 · ClinicalTrials.gov registry record · NA
Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction
A NA study, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02762825 is a NA study that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 16 participants.
The verdict
NCT02762825, a NA study, was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Patients with HFpEF suffer from exercise intolerance, increased risk for hospitalization and mortality, and poor QOL. Unlike patients with HFrEF, no drug or device therapies appear to be consistently beneficial in treating these problems. However, increasing evidence suggests that exercise training is effective for both partially reversing exercise intolerance and improving quality of life in these patients. Most such trials to date have been conducted in controlled research setting, versus integrating these patients in to a standard CR program. Also, since functional capacity is related to outcomes in these patients, exercise strategies aimed at further improving fitness are warranted. One such strategy is using higher intensity interval training (HIIT) in the CR setting, a strategy shown to be effective in patients with other types of CVD. This project is designed to test the feasibility of incorporating these patients into the CR setting, and training them using a methodology (i.e., HIIT) already shown to yield (in other patients with CVD) greater gains in fitness when compared to what was achieved using standard MCT alone.
Interventions
- BEHAVIORAL HIIT
- BEHAVIORAL MCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2022-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02762825
The ClinicalTrials.gov registry entry for NCT02762825 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HIIT is the first listed.
NCT02762825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02762825 about?
NCT02762825 is a clinical study titled "Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction". Patients with HFpEF suffer from exercise intolerance, increased risk for hospitalization and mortality, and poor QOL. Unlike patients with HFrEF, no drug or device therapies appear to be consistently beneficial in treating these problems. However, increasing evidence suggests that exercise training ...
What is the current status of trial NCT02762825?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2016-03-01. Estimated completion is 2022-09-27.
What interventions are being tested in trial NCT02762825?
The interventions under investigation include: HIIT (BEHAVIORAL), MCT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02762825?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.